Phytochemicals as Regulators of Genes Involved in Synucleinopathies

Phytochemicals as Regulators of Genes Involved in Synucleinopathies

Synucleinopathies are a group of neurodegenerative diseases characterized by the accumulation of α-synuclein aggregates in neurons, nerve fibers or glial cells. Three main types of diseases belong to the synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy....

Full description

Bibliographic Details
Main Authors:	Andrei Surguchov, Libby Bernal, Alexei A. Surguchev
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Biomolecules
Subjects:	synucleinopathies Parkinson’s disease α-synuclein epigenetics neurodegeneration protein aggregation
Online Access:	https://www.mdpi.com/2218-273X/11/5/624

Similar Items

Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
by: Natalia Siwecka, et al.
Published: (2023-07-01)

Synucleins: New Data on Misfolding, Aggregation and Role in Diseases
by: Andrei Surguchov, et al.
Published: (2022-12-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
by: Wen Li, et al.
Published: (2024-03-01)

Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson’s Disease and Synucleinopathies
by: Cristine Betzer, et al.
Published: (2018-11-01)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
by: Miguel Lemos, et al.
Published: (2020-09-01)

A New Rise of Non-Human Primate Models of Synucleinopathies
by: Margaux Teil, et al.
Published: (2021-03-01)

A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
by: Karima Schwab, et al.
Published: (2018-01-01)

From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
by: Antonio Heras-Garvin, et al.
Published: (2020-09-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
by: Marie-Laure Arotcarena, et al.
Published: (2019-06-01)

Chronic Caffeine Treatment Protects Against α-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum
by: Yanan Luan, et al.
Published: (2018-05-01)

Amyloidosis and Longevity: A Lesson from Plants
by: Andrei Surguchov, et al.
Published: (2019-05-01)

Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01)

Enteric synucleinopathy: real entity or only a trendy concept?
by: Adrien de Guilhem de Lataillade, et al.
Published: (2020-08-01)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
by: Matthias Schmitz, et al.
Published: (2023-03-01)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
by: Jacob S. Deyell, et al.
Published: (2023-01-01)

From the baker to the bedside: yeast models of Parkinson's disease
by: Regina Menezes, et al.
Published: (2015-07-01)

Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
by: Yan Sun, et al.
Published: (2020-02-01)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)

Biochemical Fractionation of Human α-Synuclein in a <i>Drosophila</i> Model of Synucleinopathies
by: Khondamir Imomnazarov, et al.
Published: (2024-03-01)

Cell Responses to Extracellular α-Synuclein
by: Alexei A. Surguchev, et al.
Published: (2019-01-01)

Fishing for synucleinopathy models
by: Suzita Mohd Noor, et al.
Published: (2022-03-01)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01)

Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm
by: Samuel Peña-Díaz, et al.
Published: (2020-10-01)

Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
by: Bradley Roberts, et al.
Published: (2022-08-01)

Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01)

How Lazy Reading and Semantic Sloppiness May Harm Progress in Synucleinopathy Research
by: Erwan Bezard
Published: (2022-01-01)

In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
by: Mohamed E. Elnageeb, et al.
Published: (2023-09-01)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01)

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight
by: Mohammed Al-Azzani, et al.
Published: (2022-02-01)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)

Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
by: Alexei A. Surguchev, et al.
Published: (2017-07-01)

Quiescent Elongation of α-Synuclein Pre-form Fibrils Under Different Solution Conditions
by: Hengxu Mao, et al.
Published: (2022-05-01)

Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
by: Kensuke Ikenaka, et al.
Published: (2019-07-01)

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
by: Veronica Ghiglieri, et al.
Published: (2018-05-01)

Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
by: Abbie T. Rodger, et al.
Published: (2023-07-01)

Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
by: Scott C. Vermilyea, et al.
Published: (2022-07-01)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
by: Megan F. Duffy, et al.
Published: (2018-09-01)

Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
by: Andrei Surguchov, et al.
Published: (2023-04-01)